NCT04535349View on ClinicalTrials.gov

Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis

NARecruitingINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 8, 2020

Primary Completion Date

June 15, 2025

Study Completion Date

June 15, 2025

Conditions
Amyloidosis Transthyretin
Interventions
DIAGNOSTIC_TEST

Whole-body & CZT bone tracer imaging (SPECT)

Quantitative analysis of myocardial uptake of 99mTc-labeled bone radiopharmaceuticals using new whole-body CZT-based SPECT-CT cameras

Trial Locations (2)

14000

RECRUITING

CHU de Caen, Caen

59000

RECRUITING

Clinique du Bois, Lille

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University Hospital, Caen

OTHER